Effect of tezepelumab in patients with severe, uncontrolled asthma by age of onset, allergic status, and eosinophilic phenotype

被引：1
|
作者：
Mathur, S. K. [1 ]
Hill, J. L. [2 ,3 ]
Ambrose, C. S. [4 ]
Martin, N. [5 ,6 ,8 ,9 ]
Llanos, J-P [7 ]
Martin, N. [5 ,6 ,8 ,9 ]
Colice, G. [10 ]
机构：
[1] Univ Wisconsin, Dept Med, Div Allergy Pulm & Crit Care Med, Madison, WI USA
[2] San Tan Allergy & Asthma, Arizona Allergy & Immunol Res, Gilbert, AZ USA
[3] Arcadia Allergy & Asthma, Phoenix, AZ USA
[4] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Gaithersburg, MD USA
[5] AstraZeneca, BioPharmaceut RandD, Resp & Immunol, Biometr,Late Stage Dev, Waltham, MA USA
[6] Cytel Inc, Waltham, MA USA
[7] Amgen Inc, Global Med Affairs, Thousand Oaks, CA USA
[8] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Cambridge, England
[9] Univ Leicester, Leicester, Leics, England
[10] AstraZeneca, Late Stage Dev, Resp & Immunol, BioPharmaceut RandD, Gaithersburg, MD USA
来源：
THORAX | 2023年 / 78卷 / SUPPL_4期
关键词：
D O I：
10.1136/thorax-2023-BTSabstracts.125
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S119
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [31] Tezepelumab for Patients with Severe Uncontrolled Asthma: A Systematic Review and Meta-Analysis
    Zoumot, Zaid
    Al Busaidi, Nasser
    Tashkandi, Wail
    Aljohaney, Ahmed A.
    Isse, Said
    Vidyasagar, Kota
    Ukwaja, Kingsley Nnanna
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 1665 - 1679
  • [32] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Welte, T.
    Menzies-Gow, A.
    Israel, E.
    Corren, J.
    Hunter, G.
    Cook, W.
    Colice, G.
    Lanos-Ackert, P. J.
    PNEUMOLOGIE, 2022, 76 : S12 - S12
  • [33] Is Efficacy of Tezepelumab Independent of Severe Asthma Phenotype?
    Brusselle, Guy
    Riemann, Sebastian
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (01) : 1 - 3
  • [34] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Menzies-Gow, Andrew
    Corren, Jonathan
    Israel, Elliot
    Welte, Tobias
    Ambrose, Christopher S.
    Cook, Bill
    Hunter, Gillian
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [35] Letter: an allergic phenotype in patients with eosinophilic oesophagitis and asthma
    Philpott, H.
    Gibson, P. R.
    Thien, F.
    Nandurkar, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (07) : 755 - 756
  • [36] Change in FeNO with dupilumab and tezepelumab in severe eosinophilic asthma
    Gates, J.
    Hearn, A.
    Maynard-Paquette, A. C.
    Green, L.
    Thomson, L.
    Fernandes, M.
    Roxas, C.
    Lam, J.
    d'Ancona, G.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2023, 78 (SUPPL_4) : A274 - A274
  • [37] Effect of tezepelumab on exacerbation-related intravenous corticosteroid use in patients with severe, uncontrolled asthma in NAVIGATOR
    Bourdin, A.
    Martin, N.
    Ambrose, C.
    Ponnarambil, S.
    Hunter, G.
    Molfino, N.
    Cook, B.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [38] Patients with allergic and eosinophilic asthma in the German severe asthma registry
    Holstege, Johannes
    Jahn, Antje
    Schulz, Christian
    Bergmann, Karl -Christian
    Koch, Andrea
    Ehmann, Rainer
    Hamelmann, Eckard
    Buhl, Roland
    Korn, Stephanie
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [39] Tezepelumab improved chronic eosinophilic pneumonia in severe asthma patients with liver cirrhosis
    Inaba, Mizuki
    Shimizu, Yasuo
    Nakamura, Yusuke
    Okutomi, Hiroaki
    Takemasa, Akihiro
    Niho, Seiji
    FRONTIERS IN MEDICINE, 2024, 11
  • [40] Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab
    Bolton, Clare
    Harrison, Tim
    Lugogo, Njira
    Fuhlbrigge, Anne
    Hirsch, Ian
    Bengtsson, Thomas
    Peterson, Stefan
    Sidaway, Martin
    Gil, Esther Garcia
    Fageras, Malin
    Da Silva, Carla A.
    ERJ OPEN RESEARCH, 2024, 10 (02)
12345